0001652786-16-000003.txt : 20161114 0001652786-16-000003.hdr.sgml : 20161111 20161114160622 ACCESSION NUMBER: 0001652786-16-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 EFFECTIVENESS DATE: 20161114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adjuvance Technologies Inc. CENTRAL INDEX KEY: 0001652786 IRS NUMBER: 270510244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-248000 FILM NUMBER: 161994811 BUSINESS ADDRESS: STREET 1: 16 WEST 22ND STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 2128459809 MAIL ADDRESS: STREET 1: 16 WEST 22ND STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 D/A 1 primary_doc.xml X0707 D/A LIVE 0001652786 Adjuvance Technologies Inc. 16 WEST 22ND STREET, 6TH FLOOR NEW YORK NY NEW YORK 10010 2128459809 DELAWARE None None Corporation true Jeffrey Gardner 116 West 22nd Street, #1 New York NY NEW YORK 10011 Executive Officer Christopher Frigon 1271 Avenue of the Americas, Suite 4300 New York NY NEW YORK 10020 Executive Officer Tyler Martin 5200 Quarry Ledge Rd. Roca NE NEBRASKA 68430 Executive Officer Director Mary Gin 209 Young Avenue Pelham NY NEW YORK 10803 Director Phil Livingston 156 East 76th Street, Apt 6C New York NY NEW YORK 10075 Director Gregory Poland 1079 Plummer Lane S.W. Rochester MN MINNESOTA 55902 Director John Gallo 45 East 89th Street, #25G New York NY NEW YORK 10128 Director Biotechnology $1 - $1,000,000 06b true 0001652786-15-000001 2015-08-06 true true true false 25000 7000000 2717694 4282306 false 15 0 0 0 false Adjuvance Technologies Inc. Christopher Frigon Christopher Frigon Corporate Secretary 2016-11-14